Drug Innovation and Design Inc.
This article was originally published in Start Up
Executive Summary
Drug Delivery; Cancer-selective delivery; topical delivery of antivirals. DIAD's topical herpes treatment is a lipophilic prodrug involving a chemically-modified version of acyclovir. For cancer, DIAD is developing a way to selectively target cancerous cells based on the ratio of tumor-associated enzymes to enzymes found in all cells.